Truemeds Eyes DealShare Acquisition At $90 Mn, 95% Below Peak Valuation: Report

Ecommerce unicorn DealShare is reportedly in advanced talks to be acquired by online pharmacy Truemeds through a share-swap transaction. The proposed deal could value DealShare at a little over $90 Mn, a steep fall from its peak valuation of $1.7 Bn in 2022, the Economic Times reported. Entrackr was the first to report that DealShare was in talks for a potential acquisition.